Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. SB
SB logo

SB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Safe Bulkers Inc (SB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
6.050
1 Day change
-3.66%
52 Week Range
6.670
Analysis Updated At
2026/03/20
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Safe Bulkers Inc (SB) does not present a strong buy opportunity at the moment for a beginner, long-term investor with $50,000-$100,000 to invest. The lack of strong trading signals, neutral technical indicators, and weak financial performance in the latest quarter suggest that waiting for a clearer entry point or better fundamentals may be prudent.

Technical Analysis

The MACD histogram is negative (-0.044) and contracting, indicating bearish momentum. RSI is neutral at 59.8, and moving averages are converging, showing no clear trend. Key support and resistance levels are close to the current price (6.28), with resistance at 6.328 and support at 5.919, suggesting limited immediate upside potential.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options data indicates a strong bullish sentiment with a very low put-call ratio, but the trading volume is relatively low, which limits its reliability as a strong indicator.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
6
Buy
6

Positive Catalysts

  • NULL identified. No recent news or significant events to drive the stock higher.

Neutral/Negative Catalysts

  • Weak financial performance in Q4 2025, with a significant drop in net income (-43.34% YoY), EPS (-31.25% YoY), and gross margin (-8.55% YoY). No recent insider or hedge fund activity to suggest confidence in the stock.

Financial Performance

In Q4 2025, revenue increased slightly by 1.51% YoY to $72.57 million. However, net income dropped significantly by 43.34% YoY to $9.84 million, and EPS fell by 31.25% YoY to $0.11. Gross margin also declined by 8.55% YoY to 42.04%, indicating weaker profitability.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target data available for evaluation.

Wall Street analysts forecast SB stock price to rise
Analyst Rating
0
Wall Street analysts forecast SB stock price to rise
Buy
Hold
Sell
0
Current: 6.280
sliders
Low
0
Averages
0
High
0
0
Current: 6.280
sliders
Low
0
Averages
0
High
0
Morgan Stanley
Robert Kad
Underweight
maintain
$34 -> $35
AI Analysis
2025-12-02
Reason
Morgan Stanley
Robert Kad
Price Target
$34 -> $35
AI Analysis
2025-12-02
maintain
Underweight
Reason
Morgan Stanley analyst Robert Kad raised the firm's price target on South Bow to C$35 from C$34 and keeps an Underweight rating on the shares. The firm is updating its price targets for North American Midstream & Renewable Energy Infrastructure stocks under its coverage, the analyst tells investors. While the framework agreement for a Canadian crude oil pipeline project and oil sands carbon capture has been finally reached, there are several unknowns that remain, the firm adds.

People Also Watch